US Stock MarketDetailed Quotes

AIM AIM ImmunoTech

Watchlist

0.2070
+0.0009+0.44%

Close Dec 4 16:00 ET

0.2113
+0.0043+2.08%

Post 16:32 ET

13.19MMarket Cap-440P/E (TTM)

AIM ImmunoTech Stock Forum

Jaguar8

Nov 27 14:33

NEWS

$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech Refutes Activist Group's False and Misleading Claims
2 minutes ago, 12:30 PM PST
Via BusinessWire
Sets Record Straight on Mischaracterization of AIM's Historical Share Price
Reminds AIM Shareholders of Activist Group's Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
Urges Shareholders to Safeguard AIM by Voting "FOR" ALL Four of the Board's Incumbent Candidates and Discarding Any Proxy Materials Receiv...

Trytosaveabit

Nov 27 14:33

News

$AIM ImmunoTech (AIM.US)$ AIM ImmunoTech Refutes Activist Group's False and Misleading Claims
2 MINUTES AGO, 3:30 PM EST
VIA BUSINESSWIRE
Sets Record Straight on Mischaracterization of AIM's Historical Share Price
Reminds AIM Shareholders of Activist Group's Numerous Lies, Omissions and Misrepresentations in Multi-Year Effort to Take Control of the Board
Urges Shareholders to Safeguard AIM by Voting "FOR" ALL Four of the Board's Incumbent Candidates and Discarding Any Proxy Materials Received...

Trytosaveabit

Nov 19 07:05

Update

$AIM ImmunoTech (AIM.US)$ AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer
4 MINUTES AGO, 8:00 AM EST
VIA GLOBENEWSWIRE
OCALA, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that data were published on Roswell Park Comprehensive Cancer Center's Phase 1 study evaluating AIM ImmunoTech's drug Ampligen® (also known as rintatolimod) ...

Jaguar8

Nov 14 14:32

13G

$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(6.84%),Steven Boyd(6.84%)

Stock_Drift

Oct 3 15:39

After Hours Ticks. 10/3…4:47pm EST.

$Intellinetics (INLX.US)$ $Lm Funding America (LMFA.US)$ $Beyond Air (XAIR.US)$ $Jianzhi Education (JZ.US)$ $China Jo-Jo Drugstores (CJJD.US)$ $Martin Midstream (MMLP.US)$ $Edesa Biotech (EDSA.US)$ $AIM ImmunoTech (AIM.US)$ $Smart Sand (SND.US)$ $SPI Energy (SPI.US)$ $Renovaro (RENB.US)$ $Phoenix Motor (PEV.US)$

Trytosaveabit

Oct 3 15:13

Hehehe

$Venus Concept (VERO.US)$ This get news that they are filing for a patent and jumps 40%! $AIM ImmunoTech (AIM.US)$ is granted a patent and price falls! Hehehe

Trytosaveabit

Oct 3 07:50

News

$AIM ImmunoTech (AIM.US)$ Reuters
4 mins ago
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis

Stock_Drift

Sep 25 04:10

9/25 Pre_Market 🚨🚨

$AtlasClear (ATCH.US)$ $VS MEDIA Holdings (VSME.US)$ $Motorsport Games (MSGM.US)$ $Eliem Therapeutics (ELYM.US)$ $ParaZero Technologies (PRZO.US)$ $AIM ImmunoTech (AIM.US)$ $XChange TEC (XHG.US)$
📊⚡️📊

MARKET-TEST-DUMMY

Sep 23 05:11

What's up here

$AIM ImmunoTech (AIM.US)$

Jaguar8

Sep 19 07:23

NEWS

$AIM ImmunoTech (AIM.US)$
AIM ImmunoTech Reports Positive Preliminary Data in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
AIM ImmunoTech (NYSE American: AIM) reported positive preliminary data from its Phase 1b/2 study of Ampligen and Imfinzi combination therapy for late-stage pancreatic cancer. The study showed stable disease in two out of three patients at 6 months in the first subject cohort. The combination therapy was generally wel...